Question 1

Cell signaling and metabolism – Which protein signaling molecule primarily increases cellular glucose uptake, and on what types of cells are its receptors found?

Accepted Answer

Introduction: Insulin is a peptide hormone central to glucose homeostasis. It promotes glucose uptake and storage and coordinates carbohydrate, lipid, and protein metabolism. This question examines recognition of insulin's role and the breadth of its receptor distribution across tissues that utilize glucose. Given Data / Assumptions: Insulin is secreted by pancreatic beta cells in response to rising blood glucose. The insulin receptor is a receptor tyrosine kinase. Many tissues respond to insulin via increased glucose uptake or metabolic reprogramming. Concept / Approach: Insulin binds its receptor on numerous target cells, triggering tyrosine kinase signaling and downstream pathways (e.g., PI3K–Akt). In skeletal muscle and adipose tissue, insulin promotes translocation of GLUT4 to the plasma membrane, increasing glucose uptake. The liver, while not using GLUT4, still responds to insulin by enhancing glycogenesis and glycolysis and suppressing gluconeogenesis. Therefore, insulin receptors are broadly expressed on many glucose-utilizing cells, not restricted to beta cells. Step-by-Step Solution: Identify the hormone for glucose uptake: insulin.Recall receptor type: receptor tyrosine kinase widely expressed.Recognize target tissues: skeletal muscle, adipose, liver, and others.Select the option reflecting broad distribution: many cell types that use glucose. Verification / Alternative check: Physiological responses to insulin—postprandial glucose disposal in muscle/adipose and hepatic glycogen synthesis—demonstrate widespread receptor-mediated effects across tissues. Why Other Options Are Wrong: Only beta cells: beta cells secrete insulin; they are not the principal uptake target. PDGF in blood: PDGF is a growth factor, not a primary regulator of glucose uptake. NGF in reflex neurons: neurotrophin, unrelated to systemic glucose uptake. Glucagon exclusively hepatocytes/adipocytes: glucagon raises blood glucose; it is not the main uptake hormone. Common Pitfalls: Assuming insulin only acts on classic GLUT4 tissues; while uptake effects are tissue-specific, insulin signaling is broadly influential. Final Answer: Insulin; many different cell types that use glucose for fuel

Question 2

Vascular biology – If a disease kills vascular endothelial cells, what happens to the normal cellular processes that mediate vasodilation?

Accepted Answer

Introduction: Endothelial cells regulate vascular tone by releasing vasoactive mediators, including nitric oxide (NO), prostacyclin, and endothelium-derived hyperpolarizing factors. This question probes the consequences of endothelial loss on vasodilation and downstream hemodynamics. Given Data / Assumptions: Endothelium synthesizes NO via endothelial nitric oxide synthase (eNOS). NO diffuses to vascular smooth muscle to activate guanylate cyclase → cGMP → relaxation. Endothelial integrity is required for normal shear-stress–dependent dilation. Concept / Approach: Killing endothelial cells eliminates a key source of NO and other relaxing factors. Without NO, smooth muscle relaxation through the cGMP pathway is blunted, limiting vasodilation. Consequently, increasing local blood flow and lowering vascular resistance become more difficult, raising perfusion pressure requirements and contributing to dysfunction such as ischemia or hypertension. Step-by-Step Solution: Link endothelial health to NO production.Remove the source (endothelium dies) → NO falls dramatically.Reduced NO → less soluble guanylate cyclase activation → lower cGMP in smooth muscle.Lower cGMP → decreased myosin light-chain phosphatase activity → less relaxation → impaired vasodilation and flow increase. Verification / Alternative check: Experimental endothelial denudation abolishes acetylcholine-induced vasodilation while leaving direct smooth-muscle vasodilators (e.g., nitroprusside) effective, showing endothelium dependency. Why Other Options Are Wrong: Each individual statement (a–c) is correct; therefore “All of the above” is the best choice. Autonomic compensation cannot fully restore endothelium-dependent dilation; response patterns change and are often insufficient. Common Pitfalls: Confusing endothelium-dependent dilation (e.g., acetylcholine) with endothelium-independent dilation (e.g., nitrates) that bypasses endothelial NO synthesis. Final Answer: All of the above

Question 3

Signal transduction – Which statement accurately describes a hydrophilic (water-soluble) signaling molecule and its mode of action?

Accepted Answer

Introduction: Hydrophilic signaling molecules (e.g., many peptide hormones, catecholamines) cannot readily cross the hydrophobic core of the plasma membrane. Their biology illustrates the principle that information can be transmitted across membranes without the ligand entering the cell, using receptors and second-messenger systems. Given Data / Assumptions: Hydrophilic ligands are water-soluble and generally membrane-impermeant. Receptors for hydrophilic ligands are usually transmembrane proteins at the cell surface. Signal amplification often occurs via second messengers such as cAMP, IP3, DAG, and Ca2+. Concept / Approach: Hydrophilic ligands bind extracellular domains of cell-surface receptors (GPCRs, receptor tyrosine kinases) to initiate intracellular signaling cascades. The downstream effectors and second messengers propagate and amplify the signal to change gene expression, metabolism, secretion, or contractility. Steroid hormones are typically hydrophobic and use intracellular receptors—opposite of the hydrophilic paradigm. Step-by-Step Solution: Classify the ligand as hydrophilic (cannot cross the lipid bilayer efficiently).Identify receptor location: plasma membrane, extracellular binding site.Describe transduction: receptor activation → G proteins/kinases → second messengers.Outcome: specific cellular responses without ligand entry into the cytosol. Verification / Alternative check: Epinephrine stimulates hepatic glycogen breakdown via a GPCR → cAMP pathway without epinephrine entering hepatocytes, proving the principle of membrane-initiated signaling. Why Other Options Are Wrong: Cytosolic/nuclear receptors: typical of hydrophobic ligands (steroids, thyroid hormone). Direct intracellular action without receptors: contradicts membrane impermeability and receptor necessity. “Necessarily a steroid”: steroids are hydrophobic, not hydrophilic. Covalent entry via transporters: not a standard requirement for signaling. Common Pitfalls: Assuming all hormones enter cells; many act entirely through surface receptors and second messengers. Final Answer: It often triggers a membrane-initiated signaling cascade that produces cellular effects

Question 4

Pharmacology/physiology – Why does inhaled nitric oxide (NO) lower blood pressure only in the pulmonary circulation and not systemically?

Accepted Answer

Introduction: Inhaled nitric oxide (iNO) is used clinically to selectively dilate pulmonary vessels, improving ventilation–perfusion matching. The selectivity arises from NO's chemistry and disposition rather than from unique pulmonary receptors. This question asks why the effect remains largely confined to lung tissue. Given Data / Assumptions: NO is a gaseous signaling molecule produced by endothelial cells. It diffuses rapidly but has a very short biological half-life. Hemoglobin binds and inactivates NO within the bloodstream. Concept / Approach: When NO is inhaled, it reaches ventilated alveoli and diffuses into adjacent pulmonary vessels, where it activates soluble guanylate cyclase in smooth muscle to raise cGMP and cause relaxation. As soon as NO encounters hemoglobin in circulating blood, it is rapidly scavenged and converted to nitrate/nitrosylated species. This confines effective vasodilation to the pulmonary vasculature and prevents systemic hypotension. Step-by-Step Solution: Deliver NO to alveoli → diffusion into nearby pulmonary arterioles.Activate sGC → cGMP ↑ → smooth muscle relaxation locally.Enter bloodstream → rapid binding to hemoglobin and oxidative inactivation.Result: negligible NO reaches distant systemic vessels; effect remains lung-selective. Verification / Alternative check: Clinical observation shows improved oxygenation and reduced pulmonary pressures without systemic hypotension at therapeutic iNO doses—consistent with rapid inactivation and localized delivery. Why Other Options Are Wrong: Different signaling molecule elsewhere: systemic vessels also use NO among others. NO cannot cross membranes: it readily diffuses across membranes. Active pumping out of systemic vessels: not a recognized mechanism. Common Pitfalls: Assuming receptor selectivity explains localization; in fact, pharmacokinetics and hemoglobin scavenging dominate. Final Answer: Nitric oxide is extremely short-lived and inactivated rapidly, limiting it to the lungs where it is delivered

Question 5

Protein interaction domains – SH2 (Src homology 2) domains specifically bind which motif on target proteins?

Accepted Answer

Introduction: Modular protein domains decode post-translational modifications to route signals inside cells. SH2 domains are classic readers of tyrosine phosphorylation, linking activated receptors and kinases to downstream effectors. This question tests knowledge of their binding specificity. Given Data / Assumptions: Tyrosine phosphorylation is a key event in receptor tyrosine kinase and cytokine receptor pathways. SH2 domains are present in many signaling proteins (e.g., Src, PI3K, Grb2, PLCγ). Binding requires both pTyr and surrounding sequence determinants. Concept / Approach: SH2 domains recognize phosphotyrosine residues embedded in short motifs, with specificity conferred by residues C-terminal to the pTyr. This enables selective recruitment of SH2-containing proteins to activated receptors or scaffolds, orchestrating pathway assembly and amplification. Step-by-Step Solution: Identify modification: phosphotyrosine (pTyr) produced by tyrosine kinases.Recognize reader: SH2 domain binds pTyr with motif selectivity.Infer outcome: localization of effectors to phosphorylated receptors.Result: pathway-specific signaling complexes form at membranes. Verification / Alternative check: Mutating the critical tyrosine to phenylalanine (cannot be phosphorylated) abrogates SH2 binding; synthetic pTyr peptides compete for binding, confirming specificity. Why Other Options Are Wrong: Phosphoserine: bound by 14-3-3 proteins or FHA domains, not SH2. GDP, Ca2+, ubiquitin: interact with other domain classes (RAS effectors, EF-hands, ubiquitin-binding domains). Common Pitfalls: Confusing SH2 with SH3 (proline-rich motif binding) or PTB (phosphotyrosine-binding with different motif rules). Final Answer: Phosphorylated tyrosine residues (pTyr) within defined sequence contexts

Question 6

Second messengers – Which of the following are considered bona fide intracellular second messengers generated downstream of receptors?

Accepted Answer

Introduction: Second messengers are small intracellular molecules that relay and amplify signals from activated receptors to downstream targets. This question distinguishes true second messengers from the enzymes that synthesize them. Given Data / Assumptions: IP3 and DAG are produced when PLC cleaves PIP2 in the membrane. Second messengers act inside the cell to modulate effectors. Enzymes like PLC catalyze formation but are not second messengers themselves. Concept / Approach: Upon receptor activation (often via GPCR Gq or RTKs), PLC hydrolyzes PIP2 into IP3 and DAG. IP3 diffuses to bind IP3 receptors on the endoplasmic reticulum, releasing Ca2+. DAG remains in the membrane, activating protein kinase C (PKC) and other effectors. Thus, IP3 and DAG fit the definition of second messengers; PLC does not. Step-by-Step Solution: Start with receptor activation → PLC recruited/activated.PLC cleaves PIP2 → generates IP3 (cytosolic) and DAG (membrane-bound).IP3 triggers Ca2+ release; DAG activates PKC.Identify second messengers: IP3 and DAG, not PLC. Verification / Alternative check: Biochemical assays show transient spikes of IP3 and DAG following receptor stimulation, with downstream PKC activation and Ca2+ transients—hallmarks of second messenger dynamics. Why Other Options Are Wrong: Phospholipase C: an enzyme, not a diffusible signaling intermediary. None of these: incorrect because both IP3 and DAG qualify. Common Pitfalls: Labeling the catalytic generator as the messenger; the messenger is the product that moves or signals further downstream. Final Answer: Both (a) and (b)

Question 7

Basic terminology – In classic cell signaling, a hormone or extracellular ligand is best described as which “messenger” in the communication chain?

Accepted Answer

Introduction: Signal transduction uses a hierarchical terminology: the extracellular signaling molecule, the receptor and associated enzymes, and intracellular second messengers. This question focuses on the correct label for the ligand itself in this sequence. Given Data / Assumptions: Ligands (hormones, neurotransmitters, growth factors) originate outside the cell or at its surface. Second messengers are generated inside the cell after receptor activation. Downstream effectors (e.g., kinases) interpret second messengers. Concept / Approach: The extracellular ligand that binds a receptor is termed the first messenger. Receptor engagement triggers intracellular enzymes to produce second messengers such as cAMP, cGMP, IP3, DAG, and Ca2+. These propagate the message to effectors that alter cell behavior. Step-by-Step Solution: Identify the position of the ligand: outside the cell or at the membrane.Define first messenger: the original extracellular signaling molecule.Contrast with second messengers: intracellular molecules generated upon receptor activation.Select “First messenger” as the correct classification. Verification / Alternative check: Canonical GPCR signaling: epinephrine (first messenger) → β-adrenergic receptor → adenylyl cyclase → cAMP (second messenger) → PKA activation, confirms the terminology. Why Other Options Are Wrong: Second messenger: reserved for intracellular mediators. Both/none/third messenger: do not match standard nomenclature. Common Pitfalls: Calling Ca2+ or cAMP “hormones”; they are intracellular messengers, not extracellular ligands. Final Answer: First messenger

Question 8

Modes of cell–cell communication – How is cell signaling commonly classified with respect to the distance over which signals act?

Accepted Answer

Introduction: Cell communication can be categorized by how far the signal travels from its source to the target. This organizational scheme helps predict kinetics, concentration ranges, and the nature of carriers or transport mechanisms required. Given Data / Assumptions: Autocrine signals act on the same cell that secretes them or nearby identical cells. Paracrine signals act locally on neighboring cells within a tissue. Endocrine signals travel via the bloodstream to distant targets. Concept / Approach: Classifying by distance yields three canonical modes: autocrine (self/very local), paracrine (local), and endocrine (systemic). Although other modes exist (synaptic, juxtacrine/contact-dependent), the distance-based triad is the core framework commonly presented in introductory cell biology and physiology. Step-by-Step Solution: List the three distance categories and their defining features.Place examples: growth factors (paracrine), cytokines (auto/paracrine), hormones (endocrine).Acknowledge additional specialized modes (e.g., synaptic) as refinements.Select the triad option as the standard classification. Verification / Alternative check: Textbook diagrams consistently depict autocrine, paracrine, and endocrine as the principal distance-based modes, with synaptic and contact-dependent signaling often treated as specialized cases. Why Other Options Are Wrong: Two types only: omits a major category. Based solely on chemical identity: ignores the spatial/transport dimension. None of the above/five by receptor family: those are different classification schemes. Common Pitfalls: Conflating classification by distance with classification by receptor mechanism (GPCR vs RTK) or by molecule type (peptides vs steroids). Final Answer: Three distinct types based on distance (autocrine, paracrine, endocrine)

Question 9

Core second messengers – Which list correctly identifies major intracellular second messengers used in many signal transduction pathways?

Accepted Answer

Introduction: Second messengers translate receptor activation into intracellular responses by regulating kinases, channels, and gene transcription. Recognizing the canonical second messengers is fundamental to understanding diverse pathways across cell types. Given Data / Assumptions: cAMP is generated by adenylyl cyclase downstream of GPCRs (Gs). cGMP is generated by guanylyl cyclase (soluble or membrane-bound). DAG arises from PIP2 cleavage by PLC and remains in the membrane. Concept / Approach: cAMP activates protein kinase A and other effectors; cGMP activates protein kinase G and certain ion channels; DAG activates conventional and novel PKC isoforms (often with Ca2+ and phosphatidylserine). Together with IP3 and Ca2+, these messengers form a core toolkit for intracellular signaling across many receptors. Step-by-Step Solution: Map each molecule to its generating enzyme and main effectors.Confirm each acts intracellularly to propagate receptor signals.Recognize that all three listed are bona fide second messengers.Choose “All of these.” Verification / Alternative check: Pharmacologic modulators (e.g., PDE inhibitors, PKC activators like phorbol esters) alter cellular responses by changing levels or actions of these messengers, underscoring their central role. Why Other Options Are Wrong: Each individual choice alone is incomplete; the question asks which list correctly identifies the major messengers among the options. Insulin is an extracellular hormone (first messenger), not a second messenger. Common Pitfalls: Confusing extracellular ligands with intracellular messengers or overlooking DAG because it is membrane-bound rather than freely diffusible. Final Answer: All of these

Question 10

Neurobiology — simple reflex arcs and their chemical messengers  In human physiology, simple nerve reflexes (e.g., the knee-jerk reflex) transmit signals across synapses using which class of signaling molecules?

Accepted Answer

Introduction: Reflexes are rapid, involuntary responses that rely on fast communication between neurons. The chemical messages that jump the tiny synaptic gap from one neuron to the next are called neurotransmitters. Understanding this core concept distinguishes synaptic messengers from intracellular second messengers or signaling enzymes. Given Data / Assumptions: Simple spinal reflex arcs involve sensory neurons, interneurons (often), and motor neurons. Neurons communicate at chemical synapses found in the spinal cord and at neuromuscular junctions. Signal transfer across a synapse requires a chemical released from the presynaptic terminal that binds receptors on the postsynaptic membrane. Concept / Approach: Neurotransmitters (such as acetylcholine, glutamate, GABA, and glycine) are stored in synaptic vesicles. An arriving action potential triggers Ca2+ influx, vesicle fusion, and transmitter release into the synaptic cleft, where it binds postsynaptic receptors to excite or inhibit the next cell, enabling the split-second timing needed for reflexes. Step-by-Step Solution: 1) Identify the site of communication in reflexes: chemical synapses in the spinal cord or at the neuromuscular junction.2) Determine which signals traverse the synaptic cleft: neurotransmitters released from presynaptic vesicles.3) Recognize that proteins like G proteins or enzymes (proteases) are intracellular participants, not the trans-synaptic messengers.4) Conclude that neurotransmitters are the correct class mediating reflex synaptic transmission. Verification / Alternative check: Electrophysiology shows miniature end-plate potentials caused by quantal neurotransmitter release. Pharmacology of reflexes (e.g., effects of curare on acetylcholine receptors) further supports the central role of neurotransmitters. Why Other Options Are Wrong: Nitric oxide is a gaseous modulator but is not the principal fast synaptic transmitter in simple reflex arcs. G proteins are intracellular transducers coupled to receptors; they are not released across synapses. Proteases are enzymes that break down proteins, not primary neural synaptic messengers. Second messengers like cAMP act inside cells; they are not secreted into blood to mediate reflex synapses. Common Pitfalls: Confusing neurotransmitters (intercellular at synapses) with second messengers (intracellular), or assuming all signaling molecules in neurons are transmitters. Final Answer: Neurotransmitters

Question 11

GPCR signaling — what immediately changes after ligand binding?  Many G-protein–linked receptors trigger short-lived changes in which class of molecules following ligand binding?

Accepted Answer

Introduction: G-protein–coupled receptors (GPCRs) translate an outside signal (first messenger) into rapid intracellular changes via second messengers. These changes are typically transient and precisely regulated to encode information without permanently altering cellular components. Given Data / Assumptions: Ligands (first messengers) bind GPCRs at the plasma membrane. Activated receptors engage heterotrimeric G proteins and downstream effectors such as adenylyl cyclase or phospholipase C. Second messengers include cAMP, cGMP, Ca2+, IP3, and DAG. Concept / Approach: Upon ligand binding, GPCRs catalyze GDP–GTP exchange on Gα, which then regulates effectors that synthesize or mobilize second messengers. The resulting brief surge of a second messenger amplifies the signal and activates protein kinases and other targets, producing a coordinated cellular response. Step-by-Step Solution: 1) Ligand binds the GPCR, causing a conformational change.2) Gα exchanges GDP for GTP and dissociates from Gβγ.3) Effectors (e.g., adenylyl cyclase, phospholipase C) generate second messengers (cAMP, IP3, DAG, Ca2+).4) Kinases (PKA, PKC, CaMK) and other sensors respond to these transient increases, initiating the response. Verification / Alternative check: Time-resolved imaging shows sharp, short-lived spikes in cAMP or cytosolic Ca2+ after GPCR activation, consistent with second-messenger dynamics. Why Other Options Are Wrong: Universal decreases (Option B) are not characteristic; responses can increase or decrease depending on receptor/effector. Options C and D conflate extracellular ligand concentrations with intracellular second messengers. Option E describes irreversible changes inconsistent with the transient, reversible nature of GPCR signaling. Common Pitfalls: Mixing up first messengers (outside) and second messengers (inside), or assuming second-messenger levels always fall rather than often rise. Final Answer: Increase in the concentration of certain intracellular signaling molecules called second messengers

Question 12

Phosphoinositide pathway — enzyme that cleaves PIP2  Which enzyme catalyzes the splitting of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol trisphosphate (IP3) and diacylglycerol (DAG) during cell signaling?

Accepted Answer

Introduction: The phosphoinositide signaling pathway is a cornerstone of GPCR and receptor tyrosine kinase signaling. A membrane-associated enzyme cleaves PIP2 to generate two pivotal second messengers: IP3 and DAG, which together mobilize Ca2+ and activate protein kinase C (PKC). Given Data / Assumptions: PIP2 resides in the inner leaflet of the plasma membrane. Upon receptor activation, a dedicated lipase cleaves PIP2. The products are IP3 (diffusible) and DAG (membrane-retained). Concept / Approach: Phospholipase C (PLC), particularly PLC-β or PLC-γ isoforms depending on receptor class, hydrolyzes PIP2. IP3 opens IP3-gated Ca2+ channels in the endoplasmic reticulum, while DAG recruits and activates PKC at the membrane, coordinating downstream responses. Step-by-Step Solution: 1) Receptor stimulation activates Gαq (GPCR) or PLC-γ (via RTKs).2) PLC hydrolyzes PIP2 → IP3 + DAG.3) IP3 diffuses to ER, triggering Ca2+ release; DAG remains in the membrane to activate PKC with Ca2+.4) PKC phosphorylates substrates to produce cellular effects. Verification / Alternative check: Biochemical assays directly measure PLC-dependent PIP2 hydrolysis and the resulting rise in IP3/Ca2+ and PKC activation. Why Other Options Are Wrong: Protein kinase C is a downstream effector activated by DAG and Ca2+, not the enzyme that cleaves PIP2. Phosphodiesterases degrade cyclic nucleotides (cAMP/cGMP), not PIP2. Lipokinase is not the canonical enzyme for this reaction. Adenylyl cyclase synthesizes cAMP from ATP, unrelated to PIP2 cleavage. Common Pitfalls: Confusing the generator of second messengers (PLC) with the kinases activated by those messengers (PKC). Final Answer: Phospholipase C

Question 13

Prostaglandins and hormone signaling — identify the incorrect statement  Which one of the following statements about prostaglandins and lipophilic hormones is incorrect?

Accepted Answer

Introduction: Prostaglandins are lipid-derived mediators that usually act locally through GPCRs, whereas classic lipophilic hormones (steroids and thyroid hormone) generally signal through intracellular receptors that regulate gene expression. Distinguishing these categories helps clarify where receptors are located and how signals are transduced. Given Data / Assumptions: Prostaglandins derive from arachidonic acid via cyclooxygenase pathways. They act primarily in a paracrine/autocrine fashion and bind cell-surface GPCRs. Steroid and thyroid hormones are lipophilic and commonly use intracellular nuclear receptors. Concept / Approach: The incorrect claim would conflate “principal lipophilic hormones” with prostaglandins at plasma membranes. While prostaglandins are lipidic and have membrane GPCRs, the principal lipophilic hormones in endocrine physiology are steroids and thyroid hormone, which predominantly use intracellular receptors, not plasma-membrane receptors. Step-by-Step Solution: 1) Identify receptor location for prostaglandins: plasma-membrane GPCRs (local action).2) Identify receptor location for steroid/thyroid hormones: intracellular/nuclear receptors (endocrine, systemic action).3) Determine which statement misrepresents these roles: Option A elevates prostaglandins as the principal lipophilic hormones at plasma membranes, which is misleading. Verification / Alternative check: Endocrinology texts classify glucocorticoids, mineralocorticoids, sex steroids, and thyroid hormone as lipophilic endocrine hormones acting via intracellular receptors; prostaglandins are eicosanoids with local GPCR signaling. Why Other Options Are Wrong: Option B is correct: biosynthesis from arachidonic acid is textbook. Option C is correct: they are paracrine/autocrine mediators. Option E is correct: it accurately contrasts steroid/thyroid signaling with membrane receptors. Option D (“None of the above”) cannot be correct because A is incorrect. Common Pitfalls: Assuming all lipophilic messengers use the same type of receptor; overlooking that prostaglandins are not typically endocrine “principal hormones.” Final Answer: The principal lipophilic hormones that bind to receptors located in plasma membranes are prostaglandins

Question 14

Modes of intercellular communication — defining paracrine signaling  In paracrine signaling, a cell releases a chemical messenger that affects which targets?

Accepted Answer

Introduction: Cells communicate through endocrine, paracrine, autocrine, and synaptic modes. Paracrine signaling is characterized by local action in the tissue microenvironment rather than systemic distribution through the blood. Given Data / Assumptions: Paracrine mediators diffuse short distances in extracellular fluid. They are often rapidly degraded or taken up, limiting range. Endocrine signals, in contrast, travel via the bloodstream to distant organs. Concept / Approach: Define each mode and match the definition: paracrine targets nearby cells; autocrine targets the same cell; endocrine targets distant cells; synaptic targets are across specialized junctions. The local nature of paracrine action makes Option A correct. Step-by-Step Solution: 1) Identify the messenger’s route: diffusion in local extracellular space.2) Establish range: micrometers to millimeters, not systemic.3) Conclude that only neighboring target cells are affected. Verification / Alternative check: Examples include prostaglandins, nitric oxide, and growth factors acting within tissues, observed in developmental biology and inflammation. Why Other Options Are Wrong: Option B describes endocrine signaling. Option C conflates endocrine with paracrine. Option D describes no signaling; autocrine is signaling to the same cell, not “no cells.” Option E refers to synaptic signaling, not general paracrine diffusion. Common Pitfalls: Confusing paracrine with endocrine simply because both involve secreted factors. Final Answer: Only target cells close to the cell from which it was secreted

Question 15

Hormone signaling cascades — adrenaline versus thyroxine  A signaling cascade triggered by adrenaline (epinephrine) or by thyroxine (T4) has which reliably true feature?

Accepted Answer

Introduction: Adrenaline and thyroxine signal through different receptor classes: adrenaline acts via GPCRs at the plasma membrane; thyroxine (T4) is a lipophilic hormone that crosses membranes and binds nuclear receptors. Despite this difference, both ultimately modulate enzymatic activities to produce physiological effects. Given Data / Assumptions: Adrenaline → GPCR → G protein → second messengers → kinases (rapid enzymatic cascades). Thyroxine → nuclear receptor → gene transcription → altered enzyme expression (slower genomic effects). Both pathways culminate in enzyme activation or changes in enzyme levels. Concept / Approach: Evaluate each option against both hormones. A and B are true for adrenaline but not for thyroxine (which uses intracellular receptors and does not require G proteins). The common, reliable statement is that signaling causes activation or regulation of enzymes necessary for the cellular response, making Option C correct. Step-by-Step Solution: 1) Map adrenaline signaling: GPCR → Gαs/Gαq → adenylyl cyclase/PLC → PKA/PKC → enzyme phosphorylation.2) Map thyroxine signaling: T4 → deiodination to T3 → nuclear receptor → transcriptional program → increased/decreased enzyme synthesis.3) Identify the shared outcome: enzymatic machinery changes drive the effect (rapid for adrenaline, slower for thyroid hormone). Verification / Alternative check: Physiology shows adrenaline rapidly activates glycogen phosphorylase (via PKA), while thyroid hormones increase basal metabolic rate by upregulating mitochondrial and metabolic enzymes. Why Other Options Are Wrong: Option A: Thyroid hormone response does not begin at a surface receptor. Option B: Thyroxine does not require heterotrimeric G proteins. Option D: Since A and B fail for thyroxine, “all of the above” is incorrect. Option E: Contradicts abundant data showing enzyme activation/regulation by both hormones. Common Pitfalls: Assuming all hormones use GPCRs or that genomic signaling lacks enzymatic consequences. Final Answer: It results in activation of a sequence of enzymes required for the cell’s effect

Question 16

Autophosphorylation in signaling — why is it effective?  Self-phosphorylation (autophosphorylation) is a powerful way to trigger specific catalytic functions in signaling proteins because it:

Accepted Answer

Introduction: Many receptors and kinases activate themselves by adding phosphate groups to specific residues within their own structure. This autophosphorylation event is a classic molecular switch that alters protein conformation and interaction surfaces to drive downstream signaling. Given Data / Assumptions: Tyrosine kinase receptors (e.g., RTKs) and some serine/threonine kinases autophosphorylate upon stimulation. Phosphorylation creates docking sites or relieves autoinhibition. Conformational changes modulate catalytic efficiency and substrate binding. Concept / Approach: Phosphate groups carry negative charge and can reorganize intra-protein hydrogen bonding and electrostatics. This can open an active site, align catalytic residues, or create binding motifs (e.g., SH2/PTB docking), thereby switching on enzymatic activity and assembling signaling complexes. Step-by-Step Solution: 1) Ligand binding induces receptor dimerization or conformational change.2) Kinase domains cross-phosphorylate specific tyrosines/serines/threonines (autophosphorylation).3) Added phosphates alter conformation and create interaction sites for effectors.4) Activated complexes propagate the cascade by phosphorylating downstream targets. Verification / Alternative check: Structural studies reveal activation loop phosphorylation correlating with an open, active conformation and increased catalytic turnover. Why Other Options Are Wrong: Option B suggests indiscriminate ligand capture; specificity is maintained by binding pockets, not phosphorylation alone. Option C confuses membrane permeability with signaling; phosphorylation does not make membranes permeable to hydrophilic ligands. Option E is incorrect; autophosphorylation activates rather than destroys the kinase domain. Common Pitfalls: Assuming phosphorylation only turns proteins on; sometimes it also turns them off, but in the context of activation, conformational change is key. Final Answer: Changes the protein’s shape and thereby its enzymatic activity

Question 17

Identifying signaling molecules Which of the following is not a signaling molecule but rather an intracellular effector enzyme in many pathways?

Accepted Answer

Introduction: Signaling molecules (first messengers) are extracellular cues such as hormones and neurotransmitters. In contrast, enzymes like adenylyl (adenylate) cyclase reside inside the cell and generate second messengers, translating receptor activation into intracellular signals. Given Data / Assumptions: Testosterone, insulin, thyroxine, and epinephrine are canonical extracellular signals. Adenylate cyclase synthesizes cAMP from ATP when activated by Gαs or other inputs. Second messengers act within the cytosol to propagate signals. Concept / Approach: Differentiate outside-in signals from inside-cell effectors. The former bind receptors; the latter are activated downstream to create the intracellular messenger landscape that controls kinases and channels. Step-by-Step Solution: 1) Classify each option as extracellular ligand vs intracellular enzyme.2) Recognize adenylyl cyclase as a membrane-embedded enzyme activated by GPCR pathways.3) Conclude it is not a signaling molecule but a generator of the second messenger cAMP. Verification / Alternative check: Biochemistry shows receptor activation of Gαs increases adenylyl cyclase activity, raising cAMP and activating PKA—hallmarks of intracellular effectors. Why Other Options Are Wrong: Testosterone, insulin, thyroxine, and epinephrine are well-established extracellular messengers. Common Pitfalls: Confusing first messengers (outside) with second messengers and the enzymes that make them (inside). Final Answer: Adenylate cyclase

Question 18

Receiving and decoding messages — who performs the task?  When a signaling molecule reaches its appropriate target cell, which specialized proteins receive it and initiate cellular responses?

Accepted Answer

Introduction: Cell communication requires the detection of extracellular cues by dedicated proteins that can translate binding into intracellular action. These detector proteins are receptors, which then engage transducers such as G proteins, kinases, or ion channels to produce a response. Given Data / Assumptions: First messengers bind specific receptors based on shape and chemistry. Receptors can be GPCRs, receptor tyrosine kinases, ligand-gated channels, or intracellular nuclear receptors. Downstream components amplify and diversify the signal. Concept / Approach: Separate the “receiver” from the “transducer.” Receptors are the primary receiving molecules; G proteins and kinases are part of subsequent transduction. Thus, the proper completion of the statement assigns the reception step to receptors on/in the target cell. Step-by-Step Solution: 1) Identify the arrival of the ligand (signaling molecule) at its target cell.2) Determine which proteins bind the ligand with specificity: receptors.3) Recognize that after binding, receptors recruit G proteins, kinases, or channels to produce the effect. Verification / Alternative check: Pharmacology defines drug “receptors” precisely as the macromolecules with which drugs/ligands interact to initiate a biological response. Why Other Options Are Wrong: Option A/B misplace G proteins as primary receivers; they are downstream transducers. Option D/E substitute unrelated components and break the logical flow of message reception. Common Pitfalls: Equating any downstream protein with the receptor, or assuming all receptors are at the surface; some are intracellular. Final Answer: Signaling molecule; target cell; receptors

Question 19

Why nitroglycerin relieves angina  Nitroglycerin has long been used to treat chronic chest pain. Its therapeutic effect arises because it:

Accepted Answer

Introduction: Angina pectoris results from myocardial ischemia. Nitroglycerin provides rapid symptom relief by expanding vascular capacity and improving coronary perfusion through the nitric oxide pathway. Given Data / Assumptions: Nitroglycerin is a prodrug that can release nitric oxide (NO) in vascular smooth muscle. NO stimulates soluble guanylyl cyclase, increasing cGMP. cGMP promotes smooth-muscle relaxation and vasodilation. Concept / Approach: The therapeutic mechanism hinges on NO-mediated vasodilation, which reduces preload and afterload and can increase coronary blood flow, improving oxygen delivery relative to demand and alleviating ischemic pain. Step-by-Step Solution: 1) Nitroglycerin enters vascular smooth muscle and is enzymatically converted to NO equivalents.2) NO activates soluble guanylyl cyclase → cGMP rises.3) cGMP activates protein kinase G, lowering intracellular Ca2+ and causing relaxation.4) Venodilation reduces cardiac preload; arterial dilation can enhance coronary flow, relieving angina. Verification / Alternative check: Clinical effects include rapid relief of chest pain and hemodynamic changes consistent with NO-cGMP signaling; tolerance patterns and interactions with PDE-5 inhibitors further corroborate the mechanism. Why Other Options Are Wrong: Option A: Nitroglycerin does not mimic receptors; it donates NO. Option B: It is not converted to peptide hormones. Option C: It does not shut down all contraction cascades; it relaxes smooth muscle via cGMP. Option E: It is not a beta-blocker; that is a different drug class. Common Pitfalls: Confusing NO donors with beta-blockers or calcium-channel blockers; overlooking the cGMP pathway. Final Answer: Breaks down to nitric oxide (NO), which causes vasodilation and increases blood flow to the heart

Question 20

Second messengers — cAMP and cGMP are generated from which nucleotides, and by which cyclase enzymes?

Accepted Answer

Introduction: Cyclic nucleotides are universal second messengers in cell signaling. This question checks whether you know the biochemical origins of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) and the specific cyclase enzymes that synthesize them. Given Data / Assumptions: cAMP derives from adenosine triphosphate (ATP). cGMP derives from guanosine triphosphate (GTP). Dedicated cyclase enzymes catalyze ring closure and pyrophosphate release. Concept / Approach: Adenylyl (adenylate) cyclase converts ATP to cAMP; guanylyl (guanylate) cyclase converts GTP to cGMP. These enzymes are activated by distinct upstream signals: many G protein coupled receptors regulate adenylyl cyclase via Gs or Gi, while guanylyl cyclases can be membrane bound receptors (e.g., natriuretic peptide receptors) or soluble enzymes stimulated by nitric oxide. Step-by-Step Solution: 1) Identify substrate for cAMP synthesis: ATP is the only correct precursor for cAMP.2) Identify enzyme: adenylyl cyclase catalyzes ATP → cAMP + PPi.3) Identify substrate for cGMP synthesis: GTP is converted to cGMP by guanylyl cyclase.4) Match pairs: ATP with adenylyl cyclase; GTP with guanylyl cyclase. Verification / Alternative check: Pharmacologic tools (e.g., forskolin) stimulate adenylyl cyclase to increase cAMP, while nitric oxide donors elevate cGMP via soluble guanylyl cyclase. These classic manipulations confirm the enzyme–substrate pairings in living cells. Why Other Options Are Wrong: GTP with adenylyl cyclase and ATP with guanylyl cyclase: swaps substrates and enzymes. ATP with guanylyl cyclase and GTP with adenylyl cyclase: mismatched enzyme specificity. CTP/UTP: these are not standard cyclic second messengers in this context. None of the above: incorrect because one option matches canonical biochemistry. Common Pitfalls: Confusing guanylyl cyclase with adenylyl cyclase due to similar names. Remember: cAMP comes from ATP via adenylyl cyclase; cGMP comes from GTP via guanylyl cyclase. Final Answer: ATP and GTP by the actions of adenylate cyclase and guanylate cyclase respectively.

Cell Signalling and Transduction Questions